The Latest Cardiac and Vascular News
ZUG, Switzerland, June 21, 2022 /PRNewswire/ — Berlin Heals Holding AG (Berlin Heals), a Swiss MedTech company that has developed a completely new and groundbreaking method for the therapy of heart failure and has already successfully tested it on patients, informs that the company has raised an additional CHF 5 million in investor funds within […]
CHARLESTON, S.C., June 21, 2022 /PRNewswire/ — The U.S. VasQ™ External Support Comparative Study results were presented this month for the first time globally at the VASA 2022. The study was a propensity-score matched comparison of the VasQ U.S. Pivotal Study single-arm prospective data with untreated contemporary Medicare patients who underwent arterio-venous fistula […]
— Successful first two HAV implantations in wounded Ukrainian citizens — HAVs were provided under Humacyte’s initiative to assist Ukraine humanitarian medical effort — Provides further real-world evidence of the potential of HAV treatment for trauma DURHAM, N.C., June 21, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage […]
Continuous monitoring using wearable sensors in general hospital wards may help detect patient deterioration earlier than traditional spot check methods and assist clinicians in improving patient outcomes1. Wireless monitoring allows earlier patient mobilization, a key indicator for recovery, particularly post-surgery2. This innovative technology was developed at GE Healthcare’s global center […]
Study to support U.S. FDA approval of the novel CLAAS® implant forleft atrial appendage occlusion (LAAO) and stroke prevention NASHUA, N.H., June 17, 2022 /PRNewswire/ — Conformal Medical, Inc., a medical device company developing next-generation LAAO technology, today announced the launch of the CONFORM pivotal trial with the enrollment of the first patients at two U.S. sites. The […]
TEL AVIV, Israel, June 20, 2022 /PRNewswire/ — SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, announced that on May 5th 2022 the U.S. Food and Drug Administration granted IDE approval for its “REDUCED1” Pilot study to treat Resistant Hypertension Patients with Renal […]
Recent Company Submission in Response to FDA Request Extends PDUFA Date SOUTH SAN FRANCISCO, Calif., June 17, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that, in response to a request from the U.S. Food and Drug Administration (FDA), the company recently provided additional pharmacokinetic analyses of omecamtiv mecarbil related […]
MORRISVILLE, N.C., June 20, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced the appointment of Rajeev Saggar, M.D., to the position of Chief Medical Officer. In this role, Dr. Saggar will oversee all aspects of research, clinical development, medical affairs, and regulatory affairs for […]
BELOIT, Wis.–(BUSINESS WIRE)–NorthStar Medical Technologies, LLC, a global innovator in the development, production and commercialization of diagnostic and therapeutic radiopharmaceuticals, today announced the promotion of one of its key executives. The announcement comes as NorthStar reaches a pivotal stage in its growth and industry influence. Dr. Frank Scholz has been named President […]
The partnership aims to expand both companies’ footprint in the cardiac ultrasound imaging space RALEIGH, NC and MONTREAL and BEER SHEVA, Israel, June 16, 2022 /PRNewswire/ — Intelerad Medical Systems™, a global leader in medical image management solutions, and DiA Imaging Analysis, a leading global provider of AI-based ultrasound software solutions, announced today a commercial partnership to offer DiA’s LVivo […]
